標題: Titlebook: Atypical Breast Proliferative Lesions and Benign Breast Disease; Farin Amersi,Kristine Calhoun Book 2018 Springer International Publishing [打印本頁] 作者: adulation 時間: 2025-3-21 16:11
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease影響因子(影響力)
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease影響因子(影響力)學科排名
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease網(wǎng)絡公開度
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease網(wǎng)絡公開度學科排名
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease被引頻次
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease被引頻次學科排名
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease年度引用
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease年度引用學科排名
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease讀者反饋
書目名稱Atypical Breast Proliferative Lesions and Benign Breast Disease讀者反饋學科排名
作者: 滑動 時間: 2025-3-21 23:58 作者: Aerophagia 時間: 2025-3-22 00:37
Elias Garcia-Urquia,Hiromitsu Yamagishiasive cancer at a rate of 30–50%. There remains great debate as to whether DCIS truly is cancer or simply a marker of cancer risk. With that there is also controversy about the need for therapy for DCIS. The outcome of patients with DCIS is in general favorable, but even following treatment, patient作者: Calculus 時間: 2025-3-22 06:40 作者: PLE 時間: 2025-3-22 10:31
https://doi.org/10.1007/978-3-662-07494-7mal breast tissue. Their behavior may be benign (fibroadenomas and pseudoangiomatous stromal hyperplasia (PASH)) or malignant (some phyllodes tumors). The various types of fibroepithelial lesions share many characteristics on clinical exam and imaging, though subtle differences may guide clinical di作者: 鐵砧 時間: 2025-3-22 14:05
https://doi.org/10.1007/978-3-319-53086-4 lesions have the potential to upstage to carcinoma on excisional biopsy. A number of studies have attempted to identify factors that may be associated with a low rate of upgrading to malignancy, thereby allowing conservative management to avoid unnecessary surgery. Patients with ADH on CNB continue作者: corpus-callosum 時間: 2025-3-22 20:45
The GEOMAGNET WebGIS Applicationreported that excisional biopsies of LCIS were associated with upgrade rates of 3.5–60% depending on subtypes (classic vs pleomorphic) and associated radiographic abnormality, resulting in increased rates of excisions and mastectomies. Hence, management of LCIS should be based on histological subtyp作者: 羞辱 時間: 2025-3-22 23:55
GIS and Environmental Monitoringma in situ is seven- to nine-fold that of the general population. The 35-year cumulative incidence of breast cancer with lobular carcinoma in situ is 35%, or approximately 1% per year, although more recent studies suggest the risk is higher. Women with atypical ductal and lobular hyperplasia are fou作者: monologue 時間: 2025-3-23 02:46
Geotechnologies and the Environment asymptomatic individuals at an early stage, when treatment may be more effective, less invasive, and/or less expensive. A complete risk assessment may place many women with a history of atypia at an increased risk of breast cancer. Several imaging modalities may be considered for additional screeni作者: Adenoma 時間: 2025-3-23 09:13 作者: 總 時間: 2025-3-23 10:48 作者: 地名詞典 時間: 2025-3-23 17:02 作者: peptic-ulcer 時間: 2025-3-23 18:36
https://doi.org/10.1007/978-94-009-0005-9ates vary dramatically. Mastectomy is associated with extremely low recurrence, and five randomized controlled trials have shown that radiation following breast conservation decreases the risk of local recurrence by half. Various combinations of clinicopathologic factors are also associated with low作者: 散布 時間: 2025-3-24 00:24 作者: 有抱負者 時間: 2025-3-24 02:30 作者: Esophagitis 時間: 2025-3-24 09:00
https://doi.org/10.1007/978-3-319-92657-5fibroepithelial lesions; radial scar; Lobular carcinoma; Ductal carcinoma; LCIS; surgical oncology作者: 現(xiàn)代 時間: 2025-3-24 12:14
978-3-030-06482-2Springer International Publishing AG, part of Springer Nature 2018作者: Armada 時間: 2025-3-24 16:10
Farin Amersi,Kristine CalhounP?rovides a concise, but comprehensive summary of the current management of patients with atypical breast proliferative lesions.Written by experts in the field.Supplies assessment tools for risk predi作者: faddish 時間: 2025-3-24 22:31 作者: 無可非議 時間: 2025-3-25 00:06
xperts in the field.Supplies assessment tools for risk predi??Management of atypical breast lesions continues to evolve.?There is considerable controversy as to whether these entities represent risk factors for future breast cancer or whether they are instead precursor lesions.? A better understandi作者: fibula 時間: 2025-3-25 06:26 作者: 抵制 時間: 2025-3-25 11:22
Breast Cancer Risk Prediction in Women with Atypical Breast Lesions,35%, or approximately 1% per year, although more recent studies suggest the risk is higher. Women with atypical ductal and lobular hyperplasia are four times more likely to develop breast cancer than the general population. Atypical hyperplasia confers a cumulative incidence of breast cancer of nearly 30% at 25?years.作者: glowing 時間: 2025-3-25 11:55 作者: 令人不快 時間: 2025-3-25 16:06 作者: 避開 時間: 2025-3-25 21:54
,Diagnostic Management of the?Atypical Hyperplasias: Core Biopsy Alone Versus Excisional Biopsy, to have a substantial risk of upgrade. In contrast, some patients with ALH on CNB with concordant pathologic, radiologic, and clinical information have a relatively low risk of upstaging on excision. Therefore, patients with ADH on CNB must be excised while a discussion of the risks and benefits are recommended for patients diagnosed with ALH.作者: gerontocracy 時間: 2025-3-26 00:23
Diagnostic Management of LCIS: Core Biopsy Alone Versus Core Biopsy plus Excision for Classic Versues, concordant radiological-pathological findings, and clinical presentations. Emerging data support that patients with CLCIS can be managed with chemoprevention and surveillance. On the other hand, PLCIS should be managed similar to DCIS, with surgical excision with or without radiation.作者: 嫌惡 時間: 2025-3-26 08:21
,The Role of Chemoprevention in the?Prevention of Breast Cancer,nd have favorable cost-benefit profiles for the prophylactic use of breast cancer prevention medications. Despite the consistent data demonstrating that prevention medications reduce breast cancer risk, mean uptake and adherence to these medications in eligible patients remain low.作者: OPINE 時間: 2025-3-26 10:27 作者: 意外的成功 時間: 2025-3-26 16:35 作者: 自作多情 時間: 2025-3-26 17:20 作者: Contracture 時間: 2025-3-26 21:48 作者: 狗窩 時間: 2025-3-27 01:18
Tom P. Evans,Glen M. Green,Laura A. Carlsonfetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.作者: obeisance 時間: 2025-3-27 05:35 作者: 變形詞 時間: 2025-3-27 12:01
https://doi.org/10.1007/978-94-009-0005-9CIS deserves a careful discussion of the various treatment options, including accurate recurrence risk estimates and the relative importance to her of the risks and benefits of each option, to help her choose the optimal treatment for her.作者: 同步信息 時間: 2025-3-27 17:14
,Lobular Carcinoma In Situ: Risk Factor or?Cancer Precursor?, as a precursor lesion for invasive cancer in some cases. The primary purpose of this chapter is to detail the evidence in support of the current view, LCIS as . a risk factor, conferring increased risk of both ipsilateral and contralateral invasive carcinoma, and a non-obligate precursor lesion at or near the site of the index lesion.作者: 傀儡 時間: 2025-3-27 20:42
,Ductal Carcinoma In Situ: Risk Factor or?Cancer,arly cancer. While there is survival benefit with surgery and radiotherapy, treatment needs to be personalized, and better predictors of outcome need to be developed and tested in clinical trials to better implement therapeutic decision-making.作者: 彎曲的人 時間: 2025-3-28 00:23 作者: Foregery 時間: 2025-3-28 03:59 作者: conquer 時間: 2025-3-28 06:52
Prophylactic Mastectomy in Patients with Atypical Breast Lesions,fetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.作者: Jacket 時間: 2025-3-28 11:25
The Nonsurgical Management of Ductal Carcinoma In Situ (DCIS),ed with surgical intervention. Alternative strategies harnessing immune responses, including vaccination, are underway. Quality of life and patient reported outcomes will also guide whether nonsurgical interventions may, in future, become standard of care for selected women with DCIS.作者: micronutrients 時間: 2025-3-28 14:50
,Surgical Treatment of Ductal Carcinoma?In Situ,CIS deserves a careful discussion of the various treatment options, including accurate recurrence risk estimates and the relative importance to her of the risks and benefits of each option, to help her choose the optimal treatment for her.作者: 吞沒 時間: 2025-3-28 22:15
Yukni Arifianti,Fitriani Agustinal lobular hyperplasia, flat epithelial atypia, radial scar, papilloma, and fibroepithelial lesions, evidence is summarized regarding each lesion’s (1) association with long-term overall risk of developing breast cancer and (2) possible precursor role in cancer development.作者: penance 時間: 2025-3-29 01:08
https://doi.org/10.1007/978-3-319-53086-4 to have a substantial risk of upgrade. In contrast, some patients with ALH on CNB with concordant pathologic, radiologic, and clinical information have a relatively low risk of upstaging on excision. Therefore, patients with ADH on CNB must be excised while a discussion of the risks and benefits are recommended for patients diagnosed with ALH.作者: Tracheotomy 時間: 2025-3-29 06:18 作者: 固執(zhí)點好 時間: 2025-3-29 09:43
https://doi.org/10.1007/978-1-4615-1523-4nd have favorable cost-benefit profiles for the prophylactic use of breast cancer prevention medications. Despite the consistent data demonstrating that prevention medications reduce breast cancer risk, mean uptake and adherence to these medications in eligible patients remain low.作者: Basal-Ganglia 時間: 2025-3-29 12:10
The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors?,ter, the definitions of risk markers and precursor lesions are defined and explored. We summarize the contemporary paradigm of breast carcinogenesis and how atypical lesions of the breast may fit into the estrogen receptor-positive cancer development pathways. For atypical ductal hyperplasia, atypic作者: DIS 時間: 2025-3-29 18:09 作者: 咽下 時間: 2025-3-29 20:42
,Ductal Carcinoma In Situ: Risk Factor or?Cancer,asive cancer at a rate of 30–50%. There remains great debate as to whether DCIS truly is cancer or simply a marker of cancer risk. With that there is also controversy about the need for therapy for DCIS. The outcome of patients with DCIS is in general favorable, but even following treatment, patient作者: Ptsd429 時間: 2025-3-30 01:36 作者: 整頓 時間: 2025-3-30 05:03
Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated?,mal breast tissue. Their behavior may be benign (fibroadenomas and pseudoangiomatous stromal hyperplasia (PASH)) or malignant (some phyllodes tumors). The various types of fibroepithelial lesions share many characteristics on clinical exam and imaging, though subtle differences may guide clinical di作者: MILK 時間: 2025-3-30 10:33 作者: 狼群 時間: 2025-3-30 14:00
Diagnostic Management of LCIS: Core Biopsy Alone Versus Core Biopsy plus Excision for Classic Versureported that excisional biopsies of LCIS were associated with upgrade rates of 3.5–60% depending on subtypes (classic vs pleomorphic) and associated radiographic abnormality, resulting in increased rates of excisions and mastectomies. Hence, management of LCIS should be based on histological subtyp作者: NEX 時間: 2025-3-30 20:23